CAF: Riding the Rail Renaissance with Record Backlog and Hydrogen Innovation

CAF (Construcciones y Auxiliar de Ferrocarriles) is a leading global manufacturer of rolling stock and rail components, headquartered in Spain. With a market cap of approximately €2.5 billion, CAF fits perfectly within our Clean Transport Portfolio’s focus on rail, charging, and low-emission transport. The company has a record backlog of over €12 billion, providing multi-year revenue visibility. CAF is at the forefront of hydrogen fuel cell trains, with its H2 train already in service in Germany, and is benefiting from massive EU rail infrastructure spending under the Green Deal.

Investment Thesis: CAF is poised for a significant re-rating as it executes on its record backlog, improves margins through operational efficiencies, and capitalizes on the shift to low-emission rail. The company’s strong balance sheet (net debt/EBITDA <1x) and free cash flow generation support continued investment in R&D and potential shareholder returns. With the stock trading at a discount to peers like Alstom and Stadler, we see a clear path to 30%+ upside over the next 12 months.

12-Month Catalysts:

  • Delivery of major contracts in Europe, the Middle East, and Latin America, driving revenue growth and margin expansion.
  • Further orders for hydrogen trains, especially in Germany and Austria, reinforcing CAF’s leadership in zero-emission rail.
  • Potential margin improvement from cost-saving initiatives and higher-margin service contracts.

Key Risks:

  • Execution risk on large, complex projects could lead to cost overruns and delays.
  • Exposure to cyclical rail investment budgets; a slowdown in EU funding could impact order intake.

Valuation: CAF trades at ~10x forward P/E, a discount to the European rail peer average of ~15x. With expected EPS growth of 15-20% annually over the next two years, the stock offers an attractive PEG ratio below 1.0. Our price target of €45 implies 35% upside from current levels.

Balance Sheet: CAF has a solid balance sheet with net debt of €250 million (net debt/EBITDA ~0.8x) and strong free cash flow generation. The company has ample liquidity to fund its growth and R&D investments.

Risk Disclaimer: This is not financial advice. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results. Please conduct your own due diligence or consult a financial advisor before making investment decisions.